Cargando…

Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)

BACKGROUND: To examine the survival benefit of definitive concurrent chemoradiotherapy (CCRT) compared to radiotherapy alone in patients with esophageal squamous cell carcinoma (ESCC) using a real-world patient population. METHODS: This retrospective study included 2,762 patients with ESCC across te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lan, Wang, Xin, Ren, Xuejiao, Han, Chun, Xiao, Zefen, Zhu, Shuchai, Qiao, Xueying, Zhou, Zhiguo, Shen, Wenbin, Chen, Junqiang, Pang, Qingsong, Zhang, Wencheng, Zhao, Yidian, Wang, Xiaomin, Sun, Xinchen, Ge, Xiaolin, Zhang, Kaixian, Hu, Miaomiao, Li, Gaofeng, Liu, Miaoling, Wang, Yadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797428/ https://www.ncbi.nlm.nih.gov/pubmed/35116602 http://dx.doi.org/10.21037/tcr-21-505

Ejemplares similares

Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
por: Chen, Mingqiu, et al.
Publicado: (2020)

Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03)
por: Zhang, Wencheng, et al.
Publicado: (2020)

Comparative Clinical Efficacy of ‘Concurrent Chemoradiotherapy (CCRT) and Anlotinib’ Than CCRT in Patients with Locally Advanced ESCC
por: Wang, Gang, et al.
Publicado: (2022)

A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
por: Li, Chen, et al.
Publicado: (2019)

Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
por: Qin, Qin, et al.
Publicado: (2020)

Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
por: Li, Chen, et al.
Publicado: (2019)

Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
por: Han, Weiming, et al.
Publicado: (2022)

S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial
por: Wang, Xin, et al.
Publicado: (2020)

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol
por: Gao, Lin-rui, et al.
Publicado: (2020)

Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
por: Chang, Xiao, et al.
Publicado: (2021)

A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone
por: Zhang, Zhan-Jie, et al.
Publicado: (2022)

Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
por: Wang, Xin, et al.
Publicado: (2023)

HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC
por: Dong, Jing, et al.
Publicado: (2022)

Comparison of dynamic changes in the peripheral CD8(+) T cells function and differentiation in ESCC patients treated with radiotherapy combined with anti-PD-1 antibody or concurrent chemoradiotherapy
por: Wei, Hui, et al.
Publicado: (2022)

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer
por: Lim, Sung Hee, et al.
Publicado: (2021)

Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
por: Chen, Xueling, et al.
Publicado: (2017)

Abnormally high HIP1 expression is associated with metastatic behaviors and poor prognosis in ESCC
por: Sun, Ying, et al.
Publicado: (2021)

The CCRT: an inexpensive cosmic ray muon detector
por: Harpell, E, et al.
Publicado: (1995)

Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)
por: Yabuki, Kenichiro, et al.
Publicado: (2015)

Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)
por: Wang, Jian, et al.
Publicado: (2021)

Intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar in patients with pelvic locoregional recurrence of cervical cancer: Results from a hospital in the Qinghai-Tibet Plateau
por: Zhang, Kuan, et al.
Publicado: (2020)

Texture Analysis as Imaging Biomarker for recurrence in advanced cervical cancer treated with CCRT
por: Meng, Jie, et al.
Publicado: (2018)

NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2
por: Suo, Daqin, et al.
Publicado: (2020)

Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
por: Kong, Jie, et al.
Publicado: (2021)

NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study
por: Chen, Xialin, et al.
Publicado: (2019)

Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/FOXO3A signaling pathway in ESCC
por: Du, Xingyu, et al.
Publicado: (2022)

Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT
por: Meng, Jie, et al.
Publicado: (2017)

SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer
por: Chang, I-Wei, et al.
Publicado: (2018)

MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020)

DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC
por: Tao, Xiuli, et al.
Publicado: (2016)

Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model
por: Cheng, Xu, et al.
Publicado: (2023)

Prognostic value of the combined preoperative plasma fibrinogen and systemic inflammatory indexes in ESCC patients
por: Cao, Honggang, et al.
Publicado: (2023)

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study
por: Lim, Kyu-Hyoung, et al.
Publicado: (2009)

A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
por: Zhang, Tian, et al.
Publicado: (2022)

Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC
por: Gao, Hongyun, et al.
Publicado: (2012)

Novel preoperative nutritional assessment tool and prognostic model for ESCC patients
por: Xu, Jinming, et al.
Publicado: (2019)

UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines
por: Palumbo, Antonio, et al.
Publicado: (2016)

Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT
por: Zhang, Zhimin, et al.
Publicado: (2020)

CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjis5pegu89to4qqt687j4m7r0